Patients reported to the laboratory before the operation and 68 months after the operation to receive in random order, on separate days, after fasting overnight for at least 10 h, 300 ml of orange juice (containing 27 g of carbohydrate sugar) supplemented with either 25 g oligofructose-enriched inulin (inulin, OraftiSynergy1, ~92% inulin content, BENEO GmbH, Mannheim, Germany), or an equicaloric load of 15.5 g maltodextrin (MDX, Nutricia GmbH, Erlangen, Germany, see Supplemental Table 1)
Ozempic contains semaglutide, which only activates the GLP-1 receptor
GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity
GLP-1 Support Patches are not a replacement for prescription GLP-1 medications and are intended solely to support wellness routines, not to treat or prevent disease
2007;293:R9837
Both treatments significantly increased blood glucose concentrations when compared to baseline (inulin at 30 min and MDX at 30 and 60 min